Latest market price
38.87
-0.31-0.79%
OverviewShort InterestFilings
NKTRQT12Nektar Therapeutics·NASDAQ
38.87-0.79%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 20, 2026S-8Registration of employee benefit securities
Oct 01, 20268-KCurrent report
Sep 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 25, 20264Statement of changes in beneficial ownership
Sep 25, 20268-KCurrent report
Sep 25, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Sep 25, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026S-8Registration of employee benefit securities
Aug 14, 202610-QQuarterly report
Aug 13, 20268-KCurrent report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
#1 / 25 of 347
Page
▼
/ 14